Kimberly A. Reed
CIK: 0001873931
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 10, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
Disposition(D)DirectTax Obligation Award
1.2K shares at avg. $4931.20- - Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
Award(A)Direct3.8K shares- - Jun 3, 2026HASI
HA Sustainable Infrastructure Capital, Inc.
Award(A)DirectLTIP Units
3.6K shares- - May 18, 2026MNTS
Momentus Inc.
Exercise(M)Direct913 shares- - May 18, 2026MNTS
Momentus Inc.
Award(A)DirectRestricted Stock Units
6K shares- - Jun 30, 2025MNTS
Momentus Inc.
Award(A)Direct16.3K shares- - Jun 4, 2025HASI
HA Sustainable Infrastructure Capital, Inc.
Award(A)DirectLTIP Units
5.2K shares- - Nov 1, 2024MNTS
Momentus Inc.
Exercise(M)Direct2.4K shares- - Nov 1, 2024MNTS
Momentus Inc.
Exercise(M)Direct222 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 10, 2026 |  TAK TAKEDA PHARMACEUTICAL CO LTD | Disposition(D) Tax Obligation Award | 1,152 | $4931.20 | - | Direct |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Award(A) | 3,800 | - | $0 | Direct |
| Jun 3, 2026 |  HASI HA Sustainable Infrastructure Capital, Inc. | Award(A) LTIP Units | 3,553 | - | - | Direct |
| May 18, 2026 |  MNTS Momentus Inc. | Exercise(M) | 913 | - | $0 | Direct |
| May 18, 2026 | MNTS Momentus Inc. | Award(A) Restricted Stock Units | 6,039 | - | - | Direct |
| Jun 30, 2025 | MNTS Momentus Inc. | Award(A) | 16,294 | - | - | Direct |
| Jun 4, 2025 | HASI HA Sustainable Infrastructure Capital, Inc. | Award(A) LTIP Units | 5,166 | - | - | Direct |
| Nov 1, 2024 | MNTS Momentus Inc. | Exercise(M) | 2,400 | - | $0 | Direct |
| Nov 1, 2024 | MNTS Momentus Inc. | Exercise(M) | 222 | - | $0 | Direct |
1-9 of 9 transactions
About Reed Kimberly A.
Reed Kimberly A. (SEC CIK 0001873931) files insider reports with the SEC as Director of TAKEDA PHARMACEUTICAL CO LTD (TAK), Director of HA Sustainable Infrastructure Capital, Inc. (HASI) and Director of Momentus Inc. (MNTS).
Signal8 holds 7 ownership filings by Reed Kimberly A. (1 Form 3, 6 Form 4), filed between Nov 5, 2024 and Jul 6, 2026. Those filings report 9 transactions, from Nov 1, 2024 to Jul 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Reed Kimberly A.'s filings is in SANTA CLARA, CA.
Recent filings by Reed Kimberly A.
- Jul 10, 2026: Disposition to issuer transaction of TAK derivative securities (Form 4, code D).
- Jul 1, 2026: Grant or award of TAK shares (Form 4, code A).
- Jun 3, 2026: Grant or award of HASI derivative securities (Form 4, code A).
- May 18, 2026: Option exercise of MNTS shares (Form 4, code M).
- May 18, 2026: Grant or award of MNTS derivative securities (Form 4, code A).
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pacheco Rhonda Janice, President, U.S. Business Unit